|The DCN dcn (Catalog #MBS625596) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The DCN, ID (DCN, Bone Proteoglycan II, CSCD, DSPG2, PG40, PGII, PGS2, Small Leucine Rich Protein 1B, SLRR1B) reacts with Human, Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s DCN can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).
Suitable for use in ELISA and Western Blot.
Dilution: ELISA: 1:1,000
Western Blot: 1:50-1:100. Researchers should empirically determine the suitability of the DCN dcn for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The DCN dcn product has the following accession number(s) (GI #19743854) (NCBI Accession #NP_598014.1) (Uniprot Accession #P07585). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
DCN is a small cellular or pericellular matrix proteoglycan that is closely related in structure to biglycan protein. The protein and biglycan are thought to be the result of a gene duplication. This protein is a component of connective tissue, binds to type I collagen fibrils, and plays a role in matrix assembly. It contains one attached glycosaminoglycan chain. This protein is capable of suppressing the growth of various tumor cell lines.
Immunogen: Synthetic peptide selected from the Center region of human DCN (KLH). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing DCN are readily searchable from our website. Different antibodies against the same target such as DCN may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. DCN also interacts with the following gene(s): DPT, EGFR, FBN1, FN1, TGFB1, TGFB2, THBS1, VCAN. Brain Diseases, Carcinoma, Cardiovascular Diseases, Fibrosis, Inflammation, Kidney Diseases, Necrosis, Neoplasms, Neoplasms, Experimental, Nervous System Diseases are some of the diseases may be linked to DCN, ID (DCN, Bone Proteoglycan II, CSCD, DSPG2, PG40, PGII, PGS2, Small Leucine Rich Protein 1B, SLRR1B). The following patways have been known to be associated with this gene. Bone, Brain, Connective Tissue, Ear, Kidney, Lung, Muscle, Nerve, Skin, Vascular tissues are correlated with this protein.